 |
Articles: General Pharma |
Prior Articles
ImmunoGen, Inc. Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
ImmunoGen, Inc., 11/11/09
Free full text
Genmab to present data from multiple studies at ash
Genmab, 11/11/09
Free full text
Firm Offers Free Network Mgmt. Apps
HealthDataManagement, 11/11/09 RSNA Session Focuses on CPOE
HealthDataManagement, 11/11/09 WEDI Show Tackles ARRA, EDI
HealthDataManagement, 11/11/09 Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 11/11/09
Free full text
FDA Approves Pennsaid(R) Topical Solution
Covidien, 11/10/09 TRIN Pharma appoints new CEO
b3c newswire, 11/10/09 Anti-Malignancy Agent Avastin: Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer
Chugai Pharmaceutical Co., 11/10/09
Free full text
New post-hoc, pooled analysis shows SYMBICORT improved airflow obstruction in patients with COPD
AstraZeneca, 11/10/09
Free full text
Genmab announces start of ofatumumab phase iii head to head study in dlbcl
Genmab, 11/10/09
Free full text
Once-Daily INTUNIV (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
Shire, 11/10/09 Covidien Submits Label Change for Optimark Contrast Agent
Covidien, 11/10/09 Pandemic 2009 Influenza Update: Pandemrix data on co-administration with annual seasonal influenza vaccine
GlaxoSmithKline, 11/10/09
Free full text
Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
Boston Scientific, 11/10/09
Free full text
The Joint Commission Appoints New Laboratory Executive Director
Joint Commission news, 11/10/09 Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
Trials, 11/10/09
Free full text
Talmadge e. king, jr. elected to ncqa board of directors
National Committee for Quality Assurance (NCQA), 11/10/09 Basic science: Nanomaterials can damage DNA without crossing barriers
AHC Media, 11/10/09
Free full text
GlaxoSmithKline and XenoPort announce extension of GSK1838262 FDA review date to 2010
GlaxoSmithKline, 11/10/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
